These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 1529941)

  • 1. Clinical and electrophysiologic effects of magnesium sulfate on paroxysmal supraventricular tachycardia and comparison with adenosine triphosphate.
    Viskin S; Belhassen B; Sheps D; Laniado S
    Am J Cardiol; 1992 Oct; 70(9):879-85. PubMed ID: 1529941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative clinical and electrophysiologic effects of adenosine triphosphate and verapamil on paroxysmal reciprocating junctional tachycardia.
    Belhassen B; Glick A; Laniado S
    Circulation; 1988 Apr; 77(4):795-805. PubMed ID: 3349581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective evaluation of parenteral magnesium sulfate in the treatment of patients with reentrant AV supraventricular tachycardia.
    Sager PT; Widerhorn J; Petersen R; Leon C; Ryzen E; Rude R; Rahimtoola SH; Bhandari AK
    Am Heart J; 1990 Feb; 119(2 Pt 1):308-16. PubMed ID: 2301220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac electrophysiologic effects of flecainide acetate for paroxysmal reentrant junctional tachycardias.
    Hellestrand KJ; Nathan AW; Bexton RS; Spurrell RA; Camm AJ
    Am J Cardiol; 1983 Mar; 51(5):770-6. PubMed ID: 6829436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Efficacy and safety of adenosine triphosphate in the control of supraventricular paroxysmal tachycardia].
    Brandão L; de Sousa J; Barreiros MC; Vagueiro MC; Amram SS
    Rev Port Cardiol; 1994 Mar; 13(3):197-202, 191. PubMed ID: 8049086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous adenosine triphosphate disodium: its efficacy and electrophysiologic effects on patients with paroxysmal supraventricular tachycardias.
    Tajima T; Muramatsu T; Kanaka S; Yanagishita Y; Ide M; Dohi Y
    Pacing Clin Electrophysiol; 1986 May; 9(3):401-10. PubMed ID: 2423982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the electrophysiologic effects of oral sustained-release and intravenous verapamil in patients with paroxysmal supraventricular tachycardia.
    Lai WT; Voon WC; Yen HW; Chang JS; Sheu SH; Hwang YS; Chiu HF
    Am J Cardiol; 1993 Feb; 71(5):405-8. PubMed ID: 8430627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electrophysiologic and clinical effects of flecainide for recurrent paroxysmal supraventricular tachycardia.
    Hoff PI; Tronstad A; Oie B; Ohm OJ
    Am J Cardiol; 1988 Sep; 62(9):585-9. PubMed ID: 3137798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Efficacy of adenosine triphosphate in terminating supraventricular tachycardia].
    Schläpfer J; Fromer M; Kappenberger L
    Schweiz Med Wochenschr; 1993 May; 123(18):941-4. PubMed ID: 8497781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinico-electrophysiologic effects of magnesium, especially in supraventricular tachycardia].
    Vester EG
    Herz; 1997 Jun; 22 Suppl 1():40-50. PubMed ID: 9333591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Double-blind study of intravenous propafenone for paroxysmal supraventricular reentrant tachycardia.
    Hammill SC; McLaran CJ; Wood DL; Osborn MJ; Gersh BJ; Holmes DR
    J Am Coll Cardiol; 1987 Jun; 9(6):1364-8. PubMed ID: 3584724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative clinical and electrophysiologic effects of adenosine and verapamil on termination of paroxysmal supraventricular tachycardia.
    Sethi KK; Singh B; Kalra GS; Arora R; Khalilullah M
    Indian Heart J; 1994; 46(3):141-4. PubMed ID: 7821934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effects of intravenous magnesium on atrioventricular node conduction in supraventricular tachycardia.
    Stiles MK; Sanders P; Disney P; Brooks A; John B; Lau DH; Shashidhar ; Wilson L; Mackenzie L; Young GD
    Am J Cardiol; 2007 Oct; 100(8):1249-53. PubMed ID: 17920366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The diagnostic and therapeutic usefulness of adenosine triphosphate in supraventricular tachycardias].
    Pulignano G; Patruno N; Urbani P; Critelli G
    Cardiologia; 1990 Aug; 35(8):671-7. PubMed ID: 2078847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous flecainide acetate for supraventricular tachycardias.
    Hellestrand KJ
    Am J Cardiol; 1988 Aug; 62(6):16D-22D. PubMed ID: 3136630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Exogenous adenosine as an anti-arrhythmia agent].
    Tebbenjohanns J; Pfeiffer D; Schumacher B; Korte T; Jung W; Lüderitz B
    Z Kardiol; 1996; 85 Suppl 6():191-9. PubMed ID: 9064965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electrophysiologic effects and therapeutic efficacy of intravenous flecainide for termination of paroxysmal supraventricular tachycardia.
    Gambhir DS; Bhargava M; Arora R; Khalilullah M
    Indian Heart J; 1995; 47(3):237-43. PubMed ID: 7558090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose related efficacy of adenosine triphosphate in spontaneous supraventricular tachyarrhythmias.
    Moro C; Lorio N; Nuñez A; Martinez J; Novo L; Aguilera M; Madrid AH
    Int J Cardiol; 1989 Nov; 25(2):207-12. PubMed ID: 2807609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness of programmed stimulation in predicting efficacy of propafenone in long-term antiarrhythmic therapy for paroxysmal supraventricular tachycardia.
    Manz M; Steinbeck G; Lüderitz B
    Am J Cardiol; 1985 Oct; 56(10):593-7. PubMed ID: 4050693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of paroxysmal reentrant supraventricular tachycardia with flecainide acetate.
    Kim SS; Lal R; Ruffy R
    Am J Cardiol; 1986 Jul; 58(1):80-5. PubMed ID: 3728336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.